Inactive Instrument

Other languages Momenta Pharmaceuticals, Inc.

Equities

MNTA

US60877T1007

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Wall Street : clôture dans le rouge après les minutes du FOMC	20-08-20
Apple : Wall Street finit en baisse, la Fed reste inquiète pour l'économie	20-08-19
Point marchés-Wall Street finit en baisse, la Fed reste inquiète pour l'économie	20-08-19
VALNEVA :, plus forte hausse du SRD à la clôture du mercredi 19 août 2020	20-08-19
Borsa Usa, S&P 500 ancora ai massimi dopo utili Target e Lowe	20-08-19
Dpa-AFX-Überblick: UNTERNEHMEN vom 19.08.2020 - 15.15 Uhr	20-08-19
Les valeurs à suivre aujourd'hui à Wall Street	20-08-19
Momenta Pharmaceuticals : Nächster Pharma-Milliardendeal - J&J kauft für 6,5 Mrd Dollar zu	20-08-19
USA: Les valeurs à suivre à Wall Street	20-08-19
JOHNSON & JOHNSON : va mettre la main sur Momenta Pharmaceuticals pour 6,5 milliards de dollars	20-08-19
Johnson & Johnson : acquisition de Momenta	20-08-19
Johnson & Johnson will Biotechfirma Momenta für 6,5 Milliarden US-Dollar kaufen	20-08-19
Johnson & Johnson will Biotechfirma Momenta für 6,5 Milliarden US-Dollar kaufen	20-08-19
Momenta Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-10
Momenta Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Provides Revenue Guidance for the Fourth Quarter 2018	18-11-07
Momenta Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2017; Provides Revenue Guidance for the First Quarter of 2018	18-02-21
Momenta Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Provides Revenue Guidance for the Fourth Quarter of 2017	17-11-01
Momenta Pharmaceuticals, Inc. Provides Capital Expenditure Guidance for the Full Year 2017	17-05-02
Allergan : Teva plant nach Übernahme von Allergan-Generikasparte weitere Zukäufe	16-08-04
Momenta Pharmaceuticals Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016; Reiterated Financial Guidance for the Year 2016	16-08-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Momenta Pharmaceuticals, Inc.

Equities

MNTA

US60877T1007

Other languages

Filters